<DOC>
	<DOCNO>NCT02556879</DOCNO>
	<brief_summary>Anti HLA alloimmunization donor evaluate detection anti-donor specific antibody ( DSA ) underestimate factor liver transplantation may contribute dysfunction graft loss , especially among candidate retransplantation , major immunization . This study analyze immunization marker time liver retransplantation systematically patient follow-up . This allow characterize histological lesion due humoral immunization , establish investigation adapt early immunosuppressive therapy .</brief_summary>
	<brief_title>Immunization Anti HLA Liver Transplant Recipients ( DSATH )</brief_title>
	<detailed_description>Humoral rejection , related immunization patient graft , diagnose presence DSA . This serious complication , responsible dysfunction graft loss kidney heart transplant , treat strengthen immunosuppressive treatment . Humoral rejection poorly characterize liver transplantation , might explain severe dysfunction misunderstood loss liver transplant . In preliminary study liver transplantation , observe presence DSAs common among patient unexplained dysfunction ( n = 22 ) compare patient without dysfunction ( n = 69 ) ( 95 % versus 51 % ) . After liver transplantation , 20 % patient immunize , 50 % retransplantation , retransplantation , approximately 40 % patient present graft dysfunction within 2 year . The role humoral rejection graft lesion loss unknown liver transplantation DSAs evaluate histological lesion associate DSAs analyze . It essential characterize humoral rejection liver transplantation liver retransplantation ( highly immunize population ) immunization marker responsible , early management complication increase immunosuppressive therapy do kidney heart transplantation . This could limit progression graft loss . A specific anti HLA immunization donor ( DSA - Donor Specific Antibodies ) underestimate factor liver transplantation may contribute dysfunction loss liver graft , especially among candidate retransplantation , strong immune . This study look marker immunization time liver retransplantation systematically patient follow-up . This allow characterize histological lesion , establish investigation adapt early immunosuppressive therapy . Methodology , experimental design : prospective , multicenter study . Results anti HLA antibody DSA give influence team patient treatment . Inclusion pre-retransplantation visit : obtaining informed consent , HLA anti-HLA antibody . Visit 1 ( day transplant ) : Standard biology , HLA antibodies DSA , Crossmatch , Histological analysis liver de-transplantation locally centralize . Visits 2 3 ( month 1 3 post retransplantation ) : Standard biology , anti-HLA antibody DSA , liver Doppler Ultrasound ( usual center ) . Visits 4 5 ( month 12 24 post retransplantation ) , case unexplained hepatic dysfunction : Standard biology , HLA antibodies DSA , liver Doppler-Ultrasound , Fibroscan hepatic puncture biopsy : histological analysis site centralize . Number subject require : 100 patient include ( 200 patient eligible select pre-transplant consultation 100 patient retransplanted include ) . Total study duration : 5 year ( 2 year inclusion 3 year follow-up - 1 year pre wait Reth 2 year post-transplant ) Inclusion period : 2 year Duration participation patient : 3 year ( 1 year maximum pre retransplantation wait + 2 year transplantation ) Number participate center : 8</detailed_description>
	<mesh_term>Liver Extracts</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Age â‰¥ 18 year upper age limit , Candidate liver retransplantation , whatever indication , period number retransplantation Recipient social protection scheme entitle Signature informed consent HIV positive patient , Multiorgan transplantation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Liver transplantation</keyword>
	<keyword>Graft failure</keyword>
	<keyword>Donor specific antibody</keyword>
</DOC>